• Anesthesia and analgesia · Apr 2016

    Randomized Controlled Trial Multicenter Study Comparative Study

    Tranexamic Acid Compared with Placebo for Reducing Total Blood Loss in Hip Replacement Surgery: A Randomized Clinical Trial.

    • Borja Barrachina, Amanda Lopez-Picado, Maria Remon, Ana Fondarella, Ibai Iriarte, Rebeca Bastida, Alicia Rodríguez-Gascón, Maria Aranzazu Achaerandio, Maria Carmen Iturricastillo, Felipe Aizpuru, Cesar Augusto Valero, Ricardo Tobalina, and Roberto Hernanz.
    • From the *Department of Anaesthesia and Perioperative Care, Araba University Hospital, Vitoria-Gasteiz, Spain; †Araba Research Unit, Araba University Hospital, Vitoria-Gasteiz, Spain; ‡Department of Anaesthesia and Perioperative Care, Garcia Orcoyen Hospital, Estella, Spain; §Department of Radiology, Araba University Hospital, Vitoria-Gasteiz, Spain; ‖Pharmacy and Pharmaceutical Technology, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain; ¶Central Laboratory, Araba University Hospital, Vitoria-Gasteiz, Spain; #Department of Orthopaedic Surgery and Trauma, Araba University Hospital, Vitoria-Gasteiz, Spain; and **Pharmacy Service, Araba University Hospital, Vitoria-Gasteiz, Spain.
    • Anesth. Analg. 2016 Apr 1; 122 (4): 986-95.

    BackgroundTranexamic acid (TXA) reduces bleeding in patients undergoing hip replacement surgery, but optimal doses and timing have yet to be established. Our primary objective in this study was to assess total blood loss 48 hours after surgery with different regimens.MethodsThis was a multicenter, parallel-group, randomized, placebo-controlled clinical trial that included all ASA physical status I to III patients undergoing unilateral total hip replacement surgery who met the inclusion criteria. Patients were randomly allocated to 1 of 3 groups: a single-dose group (15 mg/kg TXA before the start of surgery and saline 3 hours later after the start of surgery), a 2-dose group (10 m/kg TXA before and 10 mg/kg of TXA 3 hours after the start of surgery), and a control group (saline before and 3 hours after the start of surgery). Total blood loss was calculated using a formula considering hematocrit values and blood transfusions received.ResultsWe included 108 patients in the study. Total blood loss volumes up to day 2 were 1377 ± 689, 1308 ± 641, and 2215 ± 1136 mL in the single-dose, 2-dose and control groups, respectively (P < 0.001 between the placebo and the experimental groups). Blood transfusions were given to 22.9% of patients (n = 8) in the single-dose group, 11.1% (n = 4) in the 2-dose group, and 37.8% (n = 14) in the control group (P = 0.028).ConclusionsA single preoperative dose of TXA or 2 infusions of a lower dose, preoperatively and then after 3 hours after the start of surgery, resulted in lower blood loss during the first 2 days after surgery and less need for blood transfusion, with good levels of safety.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.